ARKK vs XBI
ARK Innovation ETF vs SPDR S&P Biotech ETF
ARKK$81.73
ARK Innovation ETF
Active disruptive-innovation strategy.
Expense: 0.75%Yield: 0.00%
XBI$164.01
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.36%
Quick take
- • XBI has the lower expense ratio at 0.35% vs 0.75% for ARKK.
- • XBI pays a higher dividend yield (0.36%).
Side-by-side metrics
| Metric | ARKK | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $6.53B | $10.73B |
YTD return | 4.21% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.46 | 1.10 |
P/E ratio | 48.18 | — |
Last price | $81.73 | $164.01 |
Inception | — | — |
Issuer | ARK | State Street |
ARKK top holdings
Top holdings · ARKK
| TSLA | Tesla Inc | 10.19% |
| TEM | Tempus AI Inc Class A common stock | 5.58% |
| AMD | Advanced Micro Devices Inc | 4.98% |
| CRSP | CRISPR Therapeutics AG | 4.87% |
| HOOD | Robinhood Markets Inc Class A | 4.49% |
| SPCX | Space Exploration Technologies Corp Class A | 4.48% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.18% |
| TWST | Twist Bioscience Corp | 3.95% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 3.53% |
| BEAM | Beam Therapeutics Inc | 3.31% |
Sector breakdown · ARKK
Consumer Cyclical13.0%
Technology25.8%
Communication Services7.1%
Financial Services12.8%
Industrials9.3%
Healthcare32.0%
XBI top holdings
Top holdings · XBI
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
Sector breakdown · XBI
Financial Services0.5%
Healthcare99.5%
About ARKK
ARKK (ARK Innovation ETF) is Active disruptive-innovation strategy. Managed by ARK, the fund carries $6.5B in assets under management, an expense ratio of 0.75%. Its largest holding is Tesla Inc (TSLA), which represents 10.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.